Seelos Therapeutics Inc (NASDAQ:SEEL)
| 0.985 Delayed Data As of 3:59pm ET |  -0.025 / -2.48%Today’s Change | 0.42 Today|||52-Week Range 2.25 | -26.49% Year-to-Date |
Latest SEEL News | Press Releases
No recent news for Seelos Therapeutics Inc.
Today’s Trading
| Previous close | 1.01 |
| Today’s open | 1.01 |
| Day’s range | 0.98 - 1.04 |
| Volume | 12,056 |
| Average volume (3 months) | 1,313,814 |
| Market cap | $48.1M |
Data as of 3:59pm ET, 07/13/2020
Growth & Valuation
| Earnings growth (last year) | +79.22% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | 0.7 |
| Price/Sales | 72.57 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BNGOBionano Genomics Inc | -0.03 | -5.30% |
| MBOTMicrobot Medical Inc | -0.29 | -4.39% |
| PTEPolarityTE Inc | +0.09 | +7.26% |
| IMMPImmutep Ltd | +0.03 | +2.78% |
Data as of 3:59pm ET, 07/13/2020
Financials
| Next reporting date | August 7, 2020 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $375.0K |
| Annual profit (last year) | -$51.3M |
| Net profit margin | -13,668.00% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
